Gregory Scott Duncan - 14 Jan 2023 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Gregory Scott Duncan
Issuer symbol
CRMD
Transactions as of
14 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 17:56:13 UTC
Previous filing
15 Feb 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +20,000 $0.000000 20,000 14 Jan 2023 Common Stock 20,000 $4.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.